Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Krystosek

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Experimental Cell Research|September 1, 1986
Normal and malignant cells, including neurons, deposit plasminogen activator on the growth substrataA Krystosek, N W Seeds
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|January 1, 1988
Plasminogen activator secretion in relation to Schwann cell activitiesA Krystosek, S Verrall, N W Seeds
The Journal of Biological Chemistry|August 10, 1975
Improved methods for purification and assay of eukaryotic messenger ribonucleic acids and ribosomes. Quantitative analysis of their interaction in a fractionated reticulocyte cell-free systemA Krystosek, M L Cawthon, D Kabat
Somatic Cell and Molecular Genetics|May 1, 1990
Genome regulation in mammalian cellsT T Puck, A Krystosek, D C Chan
Somatic Cell and Molecular Genetics|September 1, 1991
Confocal microscopy of genome exposure in normal, cancer, and reverse-transformed cellsT T Puck, M Bartholdi, A Krystosek, et al.
Cancer Investigation|January 1, 1994
Reverse transformation and genome exposure in the C6 glial tumor cell lineM M Haag, A Krystosek, E Arenson, et al.
Radiology|February 24, 2021
Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic PatientsCan Özütemiz, Luke A Krystosek, An L Church, et al.
Cancer Research|August 1, 1995
The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21ras but does not affect their function or localizationM B Dalton, K S Fantle, H A Bechtold, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Experimental Cell Research|September 1, 1986
Normal and malignant cells, including neurons, deposit plasminogen activator on the growth substrataA Krystosek, N W Seeds
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|January 1, 1988
Plasminogen activator secretion in relation to Schwann cell activitiesA Krystosek, S Verrall, N W Seeds
The Journal of Biological Chemistry|August 10, 1975
Improved methods for purification and assay of eukaryotic messenger ribonucleic acids and ribosomes. Quantitative analysis of their interaction in a fractionated reticulocyte cell-free systemA Krystosek, M L Cawthon, D Kabat
Somatic Cell and Molecular Genetics|May 1, 1990
Genome regulation in mammalian cellsT T Puck, A Krystosek, D C Chan
Somatic Cell and Molecular Genetics|September 1, 1991
Confocal microscopy of genome exposure in normal, cancer, and reverse-transformed cellsT T Puck, M Bartholdi, A Krystosek, et al.
Cancer Investigation|January 1, 1994
Reverse transformation and genome exposure in the C6 glial tumor cell lineM M Haag, A Krystosek, E Arenson, et al.
Radiology|February 24, 2021
Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic PatientsCan Özütemiz, Luke A Krystosek, An L Church, et al.
Cancer Research|August 1, 1995
The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21ras but does not affect their function or localizationM B Dalton, K S Fantle, H A Bechtold, et al.
Pageof 2